Images, video and audio from this Web site are provided without login for the purpose of editorial use only.
You must contact firstname.lastname@example.org to obtain approval for advertising, marketing or other commercial users.
Ford Media Center
DEARBORN, Mich., Aug. 16, 2019 – Ford is donating a custom 2020 Mustang Shelby® GT500® adorned in one-of-a-kind Venom paint that will be raffled to benefit JDRF and its battle against Type 1 diabetes.
The 2019 JDRF Mustang Shelby GT500 comes in a one-of-one Venom metallic clearcoat – a stealthy charcoal color – with black painted over-the-top racing stripes. It has the Carbon Fiber Track Package, including exposed carbon fiber wheels, Michelin Pilot Sport Cup 2 tires, rear seat-delete, Recaro® leather-trimmed seats and Mustang GT4 track wing.
“Building on the excitement around GT500 is a terrific way to help JDRF fund research and help find a cure for Type 1 diabetes,” said Dave Pericak, Ford director of enterprise product line management. “Not only does this raffle provide an opportunity to win the most powerful production Ford ever, it also speaks to how Ford strives to make people’s lives better.”
Ford has been donating vehicles to JDRF for its raffle fund-raiser for nearly a decade. Ford teamed up with Protean and Penske Vehicle Services to create this custom-colored pony car.
Ford and JDRF are aiming to sell 75,000 raffle tickets during this annual fundraiser to raise money for JDRF, which is an interntional leader in Type 1 diabetes research funding, programming and awareness.
The first-place raffle winner takes home the Venom Shelby GT500. The second-place winner will receive an all-inclusive VIP race experience for two to the 2020 Daytona 500.
Tickets can be purchased online at https://p2p.onecause.com/jdrfgt500 until Nov. 10. Tickets cost $10 each. The drawing will be held Nov. 14 at the Ford Conference and Event Center, 1151 Village Road, Dearborn, Mich. The winner does not need to be present at the raffle drawing to win.
2020 Mustang Shelby GT500
The all-new Mustang Shelby GT500 delivers on its heritage with 760 horsepower, delivering the quickest street-legal acceleration and most high-performance technology to date ever offered in a Ford Mustang.
Arriving this fall, the Shelby GT500 features the most power- and torque-dense supercharged V8 in the world with 760-horsepower and 625 ft.-lb. of torque from its Ford Performance 5.2-liter V8 engine. Thanks to its first-in-class Tremec® TR-9070 DCT 7-speed dual-clutch transmission, the Shelby GT500 achieves a 0-100-0 in 10.6 seconds – an acceleration experience typically reserved for supercars.
# # #
The winner is responsible for income taxes – approximately 25 percent of the vehicle’s value – vehicles taxes, licensing, insurance and shipping of any kind.
GT500 and Shelby are registered trademarks of Carroll Hall Shelby Trust. Horsepower and torque ratings are based on using fuel as per SAE J1349 standard; actual performance may vary.
Ford Motor Company is a global company based in Dearborn, Michigan. The company designs, manufactures, markets and services a full line of Ford cars, trucks, SUVs, electrified vehicles and Lincoln luxury vehicles, provides financial services through Ford Motor Credit Company and is pursuing leadership positions in electrification, autonomous vehicles and mobility solutions. Ford employs approximately 194,000 people worldwide. For more information regarding Ford, its products and Ford Motor Credit Company, please visit www.corporate.ford.com.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF